Ajanta Pharma Ltd.'s board will consider a buyback of equity shares at its board meet on Thursday, May 2, 2024, it said in an exchange filing. The company will also consider its March quarter results on the said date. This is the fourth buyback that Ajanta Pharma will be considering in as many years. The first buyback happened in November 2020, with the second one in January 2022.
Open FlipSnap Inc. SNAP shares are skyrocketing in the premarket session on Friday. Yesterday, the company reported its first-quarter financial results with quarterly earnings of 3 cents per share, beating the analyst consensus estimate of a loss of 5 cents per share. Adjusted EBITDA was $46 million, compared to $1 million in the prior year.
Open FlipBajaj Finserv reported a 20% year-on-year increase in consolidated net profit, reaching ₹2,119 crore for the fourth quarter of the financial year 2023-24, driven by strong growth from Bajaj Finance. The company’s total consolidated income surged 35.6% year-on-year to ₹32,041.93 crore. The Board of Directors has recommended a dividend of ₹1 per share, which is 100% of the face value of ₹1.
Open Flip